As insulin resistance grows, the body becomes increasingly unable to burn what you're bringing in, and goes into fat storage mode
Benvenuti, Bologna AIL and Fondazione Terzo Pilastro Internazionale
First, Point32Health, the second largest payor in the state, announced that the only drug available would be Zepbound, the obesity-approved version of tirzepatide
The FDA removed semaglutide from the official shortage list in February 2025, which narrowed the conditions under which broad compounding can continue, and the FDA has warned about fraudulent or unapproved GLP-1 products
This increase could be worsened in high-heat conditions, causing more blood to flow to the skin.[ref] Theories on the underlying causes of POTS: Research points to several theories on what causes POTS, and it is likely that the individual causes of the symptoms can be different for different people
Rates of severe nausea or vomiting were reported in 3 to 8 percent of GLP-1 users, but confirmed gastroparesis diagnoses requiring gastric emptying studies were extremely rare
